FIELD: pharmaceuticals.
SUBSTANCE: invention relates to novel compounds of tetrahydroisoquinoline derivatives of formula (I), as well as use and methods of treating a disease or condition sensitive to modulation of contraction of a skeletal muscle sarcomere.
EFFECT: obtaining novel compounds which modulate contractions of the skeletal muscle sarcomere and can be used for treating the mediated diseases.
32 cl, 10 dwg, 7 tbl, 167 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITORS OF CATECHOL-O-METHYLTRANSFERASE AND THEREOF APPLICATION IN TREATMENT OF PSYCHIC DISORDERS | 2011 |
|
RU2572624C2 |
| NEW SUBSTITUTED AZAINDOLINE DERIVATIVES AS NIK INHIBITORS | 2018 |
|
RU2780577C2 |
| PEPTIDE EPOXY KETONES FOR PROTEASOME INHIBITION | 2007 |
|
RU2450016C2 |
| OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2815636C1 |
| OPTIONALLY CONDENSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES SUITABLE FOR TREATING INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2719422C2 |
| NEW SUBSTITUTED BIARYL COMPOUNDS AS INDOLAMINE-2,3-DIOXYGENASE (IDO) INHIBITORS | 2018 |
|
RU2786586C2 |
| 2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
| PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS LEUCINE-REPEATING KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON DISEASE | 2013 |
|
RU2637948C2 |
| NEW COMPOUNDS | 2013 |
|
RU2654857C2 |
| ANTI-CANCER BENZOPYRAZINES ACTING THROUGH FGFR-KINASES INHIBITION | 2012 |
|
RU2639863C2 |
